Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-17

FDA Approved: RUGBY MOMETASONE FUROATE NASAL — Original Application (Rugby Laboratories)

View source ↗

Summary

FDA approved Rugby Mometasone Furoate Nasal from Rugby Laboratories under an original NDA. The nasal corticosteroid is indicated for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rugby Mometasone Furoate Nasal (Mometasone furoate)

Snippet

ORIG AP for RUGBY MOMETASONE FUROATE NASAL (MOMETASONE FUROATE)